General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0KFMAB
ADC Name
DXC-009
Synonyms
DXC 009; DXC-009; DXC009
   Click to Show/Hide
Organization
Hangzhou DAC Biotech Co., Ltd.
Drug Status
Phase 1
Indication
In total 1 Indication(s)
Multiple myeloma
Phase 1
Clinical Trial
Drug-to-Antibody Ratio
Undisclosed
Antibody Name
Undisclosed
Antigen Name
Undisclosed
Payload Name
Undisclosed
Linker Name
Undisclosed
Conjugate Type
Random Cysteines